TABLE 1.
Activated caspase-3 | TUNEL | COMET | Lymphocyte count | Plasma folate | |
---|---|---|---|---|---|
integrated OD/mg DNA |
% cells positive |
tail moment | × 106/mL | nmol/L | |
Baseline diet (n = 51) | 11.5 ± 1.2 | 1.6 ± 0.2 | 1.0 ± 0.1 | 2.3 ± 0.1 | 26.0 ± 0.9 |
Low-choline diet | |||||
Organ dysfunction, 100 DFE (n = 17) | 21.5 ± 3.92 | 4.2 ± 0.92 | 2.2 ± 0.2 | 2.1 ± 0.2 | 20.7 ± 1.62 |
Organ dysfunction, 768 DFE (n = 16) | 15.6 ± 4.02 | 2.0 ± 0.4 | 2.1 ± 0.2 | 2.2 ± 0.1 | 28.2 ± 1.7 |
No organ dysfunction, 100 DFE (n = 8) | 5.2 ± 1.0 | 3.3 ± 1.32 | 1.7 ± 0.2 | 2.4 ± 0.2 | 23.0 ± 2.42 |
No organ dysfunction, 768 DFE (n = 10) | 11.0 ± 2.7 | 2.4 ± 0.7 | 1.8 ± 0.2 | 2.2 ± 0.3 | 27.1 ± 2.0 |
All values are x̄ ±SE. OD, optical density; TUNEL, terminal deoxynucleotidyl transferase–mediated dUTP nick end-labeling; COMET, single-cell gel electrophoresis; DFE, dietary folate equivalents. Subjects were fed a diet providing 550 mg choline/70 kg body wt daily (baseline) for 10 d and were then fed a low-choline diet diet for up to 42 d. They were randomly assigned to receive only dietary folate (100 DFE/d) or dietary folate plus a daily folic acid supplement (combined intake: 768 DFE/d) while consuming a choline-deficient diet. The organ dysfunction×folate interaction was not significant; thus, a 2-wayANOVA based on the differences between measurements at the end of the baseline and choline-deficient periods was used to compare the groups.
Significantly different from all other choline-deficient groups, P < 0.05.